Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 26 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 17 | 6 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 5 | 2 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 3 | 10 | 4 | 0 | 0 |
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $188.31, a high estimate of $235.00, and a low estimate of $128.00. This current average reflects an increase of 7.65% from the previous average price target of $174.92.
Deciphering Analyst Ratings: An In-Depth Analysis
The perception of Sarepta Therapeutics by financial experts is analyzed through...
Login or create a forever free account to read this news
Sign up/Log in